Discovery sheds light on how cancer can spread in the wild, raising questions about where the cancer originated, and how it ...

Moxham currently leads Transcripta Bio as founder and CEO. The AI-driven drug discovery start-up is developing small molecule ...

An AI-based approach assesses disease severity in patients with myelodysplastic neoplasms (MDS), a form of blood cancer.

Genomics says it is on track to build out a CLIA-certified laboratory set to open next year, part of the spatial and ...

Cell-containing products can be checked for particulates arising mostly from single-use products using process simulation.

The team analyzed whole‑genome sequence data from 570 Schistosoma mansoni parasites collected across Africa and the Caribbean ...

Perineuronal nets stabilize memory circuits and diminish during late adolescence before rebuilding in adulthood.

UCSD has joined the Innovative Genomics Institute as its fourth UC partner, expanding collaborations to develop next-generation genome-editing technologies.

Kyle Muldoon tends to go with his gut. When a profound feeling came over him about this foreign concept, known as gene editing, he knew that an answer to a family crisis was in front of him. Kyle’s ...

Eli Lilly agreed to acquire AtaiBeckley for up to $3.8 billion—of which Lilly will pay $2.8 billion upfront. The deal, set to ...

The overall economic outlook for 2025 may show slow-but-steady growth—”above-potential GDP growth toward 2.2%,” according to EY—but the job forecast is more optimistic for the life sciences sector, ...

Biotechnology companies want to move fast without creating data and workflow challenges that limit their ability to scale.